Denali Therapeutics Inc. (DNLI) Misses Q1 EPS by 8c

Denali Therapeutics Inc. (NASDAQ: DNLI) reported Q1 EPS of ($0.78), $0.08 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Denali Therapeutics Inc. (DNLI) click here.

You May Also Be Interested In

• Mosaic (MOS), Others Lower Following Trump Post on Potash from Belarus
• FAA halts flights at major East Coast airports after telecom failure
• Qualcomm surges on AI chip deal ahead of flagship event